Clinical Trial Details

EORTC-2227-BTG

Back to Clinical Trials Database

Lomustine with and without reirradiation for first progression of glioblastoma: a randomized phase III study

Study documentation

Trial Status Recruiting
Dates Date of activation: 15-Mar-2024
Data management at EORTC Yes
Design Phase 3
Randomized open label
Targeted Sample size All Groups: 490
Treatment Radiotherapy, Drug
Lomustine
Study Staff Matthias Preusser (Study Coordinator) , Universitaetsklinikum Wien - AKH unikliniken, Vienna
Christian Alfano (Project Manager) , EORTC Headquarters, Brussels
Enrico Clementel (QART Manager) , EORTC Headquarters, Brussels
Corneel Coens (Statistician) , EORTC Headquarters, Brussels
Coreen Corning (QART Manager) , EORTC Headquarters, Brussels
Jozefien Debruyne (Junior PVM) , EORTC Headquarters, Brussels
Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels
Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels
Irina Ghislain (QoL Specialist) , EORTC Headquarters, Brussels
Lucia Gonzalez (Junior Clinical Operations Manager) , EORTC Headquarters, Brussels
Thierry Gorlia (Statistician) , EORTC Headquarters, Brussels
Tomas Kazda (Y-ECI Coordinator) , Masaryk Memorial Cancer Institute, Brno
Stephane Lejeune (International Affairs and Policies Manager) , EORTC Headquarters, Brussels
Abigirl Machingura (QoL Specialist) , EORTC Headquarters, Brussels
Sara Meloen (Pharmacovigilance Manager) , EORTC Headquarters, Brussels
Anja Mestnik (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Giuseppe Minniti (Study Co-Coordinator) , Azienda ospedaliero Univ Policlinico Umberto I, Roma
Ana Oliveira (Data Manager) , EORTC Headquarters, Brussels
Caroline Quoilin (Medical representative) , EORTC Headquarters, Brussels
Maira Seini (Senior Regulatory Affairs Manager) , EORTC Headquarters, Brussels
Luiza Souza (QART Manager) , EORTC Headquarters, Brussels
Katheline Vander Heggen (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels
Tim Verbiest (Data Manager) , EORTC Headquarters, Brussels
Zineb Wadid (Lead CRA) , EORTC Headquarters, Brussels
Christine de Balincourt (Lead CRA) , EORTC Headquarters, Brussels
Lotte van der Weijst (QoL Specialist) , EORTC Headquarters, Brussels
Type of cancer Brain
Participating groups EORTC Brain Tumor Group
Recruiting centers A.O Landeskrankenhaus - Innsbruck Universitaetsklinik (Innsbruck, Austria)
Erasmus MC (Rotterdam, Netherlands)
Kepler University Hospital - Neuromed campus (Linz, Austria)
Masaryk Memorial Cancer Institute (Brno, Czech Republic)
Medisch Spectrum Twente (Enschede, Netherlands)
Universitaetsklinikum Leipzig-Klinik fuer Strahlentherapie und Radioonkologie (Leipzig, Germany)
Universitaetsklinikum Tuebingen- Crona Kliniken (Tuebingen, Germany)
Universitaetsklinikum Wien - AKH unikliniken (Vienna, Austria)
Centers to be activated APHP Nord - Univ De Paris Cite - Hop. Saint Louis (Paris, France)
APHP Sorbonne Univ - Hopital la Pitie-Salpetriere (PARIS, France)
Azienda Unita Locale Socio-Sanitaria N. 9-Mater Salutis Hospital (Legnago, Italy)
Azienda ospedaliero Univ Policlinico Umberto I (Roma, Italy)
CHRU de Lille (LILLE CEDEX, France)
CHU Amiens Picardie - Site Sud (Amiens, France)
CHU Lyon - Hopital neurologique Pierre Wertheimer (BRON CEDEX, France)
CHU de Nice - Hopital Pasteur (NICE, France)
CLCC - Jean Perrin (CLERMONT FERRAND , France)
Cliniques Universitaires Saint-Luc (Brussels, Belgium)
ETZ - St. Elisabethziekenhuis (Tilburg, Netherlands)
Grand Hopital de Charleroi - Site Notre Dame (Charleroi, Belgium)
Hospital Universitario 12 De Octubre (Madrid, Spain)
ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain)
ICO L’Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia) (L' Hospitalet De Llobregat, Spain)
IRCCS - Istituto Oncologico Veneto (Padova, Italy)
IRCCS--Ospedale Bellaria-Bologna (Bologna, Italy)
Institut de Cancerologie de l’Ouest (ICO) - Saint Herblain (Saint Herblain CEDEX, France)
Institut du Cancer de Montpellier (MONTPELLIER CEDEX 5, France)
Istituto Clinico Humanitas (Rozzano, Milano, Italy)
Leiden University Medical Centre (Leiden, Netherlands)
Ludwig-Maximilians-Universitaet Muenchen - Campus Grosshadern (Muenchen, Germany)
Onze Lieve Vrouw Ziekenhuis (Aalst, Belgium)
Oslo University Hospital - Radiumhospitalet (Oslo, Norway)
Region Midtjylland - Aarhus University Hospital-Skejby (Aarhus, Denmark)
St. Olavs Hospital, Trondheim University Hospital (Trondheim, Norway)
U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
Univ. Knappschaft Krankenhaus Bochum (Bochum-Langendreer, Germany)
Univ. Knappschaft Krankenhaus Bochum (Bochum-Langendreer, Germany)
Universita Degli Studi Di Siena -Policlinico "le Scotte" (Siena, Italy)
UniversitaetsKlinikum Heidelberg - Head Hospital (Heidelberg, Germany)
UniversitaetsSpital Zurich - Neurology Clinic (Zurich, Switzerland)
Universitaetsklinikum Erlangen-Schwabachanlage (Erlangen, Germany)
Universitaetsklinikum Koeln (Koeln, Germany)
Universitaetsklinikum Regensburg (Regensburg, Germany)
Universitaetsspital Basel (Basel, Switzerland)
Protocol summary http://clinicaltrials.gov/study/NCT05904119
NCT number NCT05904119
Financial Support Brain Tumor Group
Horizon